Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Georgia PeakmanLucy L RussellRhian S ConveryJennifer M NicholasJohn Cornelis van SwietenLize C JiskootFermin MorenoRaquel Sanchez-ValleRobert LaforceCaroline GraffMario MasellisMaria Carmela TartagliaJames Benedict RoweBarbara BorroniElizabeth C FingerMatthis SynofzikDaniela GalimbertiRik VandenbergheAlexandre de MendonçaChris R ButlerAlexander GerhardSimon DucharmeIsabelle L E BerFabrizio TagliaviniIsabel SantanaFlorence PasquierJohannes LevinAdrian DanekMarkus OttoSandro SorbiJonathan Daniel Rohrernull nullPublished in: Journal of neurology, neurosurgery, and psychiatry (2021)
Both the FRS and CDR+NACC FTLD measure disease severity in genetic FTD mutation carriers throughout the timeline of their disease, although the FRS may be preferable as an outcome measure. However, neither address a number of key symptoms in the FTD spectrum, for example, motor and neuropsychiatric deficits, which future scales will need to incorporate.